Pacmilimab (Anti-B7-H1 / PD-L1 / CD274)
A2781
Product group Antibodies
Overview
- SupplierSelleck Chemicals
- Product NamePacmilimab (Anti-B7-H1 / PD-L1 / CD274)
- Delivery Days Customer9
- CertificationResearch Use Only
- Estimated Purity...
- Scientific DescriptionPacmilimab (anti-B7-H1 / PD-L1 / CD274) is a monoclonal antibody directed against the tumor-associated antigen (TAA) programmed cell death 1 ligand 1 (PD-L1; B7-H1; CD274) with potential immune checkpoint inhibitory and antineoplastic activities. MW: 152.6 kD.
- Storage Instruction-20°C
- UNSPSC12352203